Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

Memorial Sloan Kettering Cancer Center · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
germ cell tumor, nonseminomatous germ cell tumor, seminoma, germinomatous germ cell tumor, dysgerminoma, pineal germ cell tumor, 17-160, durvalumab, tremelimumab, medi4736, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804250
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.